Skip to content

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Study of the Effect of Sitagliptin on the Hormonal Responses to Macronutrient Ingestion in Healthy Volunteers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00885638
Enrollment
12
Registered
2009-04-22
Start date
2009-08-31
Completion date
2012-09-30
Last updated
2014-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Type 2 Diabetes

Keywords

GLP-1, Insulin secretion, Macronutrients

Brief summary

The regulation by DPP-4 inhibition after ingested of different individual macronutrients is not known. Therefore, this study examines the influence of ingestion of fat, protein, glucose or mixed meal on the concentrations of incretin hormones and insulin secretion with or without concomitant administration of a DPP-4 inhibitor (sitagliptin).

Detailed description

Meal ingestion releases gut hormones which stimulate insulin secretion. A most important gut hormone is the incretin hormone glucagon-like peptide-1 (GLP-1). GLP-1 is rapidly degraded and inactivated after its release by the enzyme dipeptidyl peptidase-4 (DPP-4). Inhibition of DPP-4 therefore increases the concentration of active GLP-1 after meal ingestion, which augments insulin secretion. How this process is regulated after ingested of different individual macronutrients is not known. Therefore, this study examines the influence of ingestion of fat, protein, glucose or mixed meal on the concentrations of incretin hormones and insulin secretion with or without concomitant administration of a DPP-4 inhibitor (sitagliptin).

Interventions

DRUGSitagliptin

100 mg sitagliptin before ingestion of macronutrient

DRUGplacebo

A placebo tablet is given before ingestion of macronutrients

Sponsors

Lund University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men * Age 20-30 years * BMI 20-30 kg/m2

Exclusion criteria

* Any disease * Any medication

Design outcomes

Primary

MeasureTime frameDescription
Glucagon-like Peptide-1 Secretion After Meal Ingestion300 minPlasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion

Secondary

MeasureTime frameDescription
Insulin Secretion After Ingestion of Meal300 minPlasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion

Countries

Sweden

Participant flow

Recruitment details

Recruitment was performed during 2011 to Lund University

Participants by arm

ArmCount
All Study Participants
Placebo first, then sitagliptin or sitagliptin first, then placebo
12
Total12

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Age, Continuous22.5 years
STANDARD_DEVIATION 1.9
Region of Enrollment
Sweden
12 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Glucagon-like Peptide-1 Secretion After Meal Ingestion

Plasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion

Time frame: 300 min

Population: Completer population

ArmMeasureValue (MEAN)Dispersion
PlaceboGlucagon-like Peptide-1 Secretion After Meal Ingestion0.82 nmol/l/minStandard Error 0.11
SitagliptinGlucagon-like Peptide-1 Secretion After Meal Ingestion1.24 nmol/l/minStandard Error 0.13
Secondary

Insulin Secretion After Ingestion of Meal

Plasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion

Time frame: 300 min

Population: Completer population

ArmMeasureValue (MEAN)Dispersion
PlaceboInsulin Secretion After Ingestion of Meal29.6 mol/l/minStandard Error 2.8
SitagliptinInsulin Secretion After Ingestion of Meal24.7 mol/l/minStandard Error 2.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026